Workshop

Intergenerational trauma (IGT) refers to the transmission of trauma from one generation to the next, significantly impacting individuals with substance use disorders (SUD) and their families. This keynote presentation will explore the intricate connection between IGT and SUD, drawing on recent research that demonstrates how trauma can influence neurodevelopment, attachment, and addiction vulnerability across generations. …

Breaking the Cycle: Interrupting Intergenerational Trauma in Substance Use Disorder Treatment Read More »

Randomized controlled trials (RCTs) are the gold standard for testing the safety and comparative effectiveness of treatments for substance use disorders (SUDs). Yet, many regions of the developing world—as well as minoritized communities in North America and Europe—are underrepresented in large, multi-centre RCTs in addiction medicine. Given these limitations, we bring together leading global experts …

Optimizing Addiction Medicine RCTs in the Developing World Read More »

A Citizens’ Assembly on Drugs Use Was established in early 2023 to examine the legislation and policies in Ireland in an effort to reduce the harmful impacts of illicit drugs on people, their families, communities and wider Irish society. The workshop presentation outlines the work of the Assembly and the recommendations contained in the report …

The Citizens Assembly on Drugs (Ireland) – summary of findings and recommendations Read More »

Background: The addicted use of new media applications, such as digital games, social media platforms, and video-streaming services, has become highly prevalent among adolescents. Associated parents are often distressed. Since the inclusion of Gaming Disorder in the ICD-11, WHO has officially recognized the clinical relevance of internet use disorders (IUDs). Though, effective and evidence-based treatment …

Res@t – Resource-Strengthening Training for Adolescents with Problematic Digital-Media Use and their Parents: pracitical introduction to a new intervention Read More »

Background International consensus statements and current research stress the importance of ADHD treatment in patients with concomitant SUD [1, 2], recommending multimodal, integrated treatment, including pharmacological and psychosocial interventions for both ADHD and SUD. ADHD medication in those with SUD is still controversial [1]. Both treatment access and treatment type vary widely across clinical sites. …

Pharmacological treatment of ADHD and comorbid SUD – improving treatment outcomes by combining research perspectives with clinical experience Read More »

Introduction/Objectives: Opioid agonist treatment (OAT) is essential for managing opioid use disorder (OUD), with buprenorphine being a preferred treatment due to its safer profile. However, its partial agonism at the mu-opioid receptor can lead to precipitated withdrawal, complicating the induction process. Innovative protocols have been developed to minimize withdrawal during induction. Our team previously reported …

Induction onto Buprenorphine utilizing transdermal patches over 24-48 hours: IPPAS method Read More »